Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Acrivon Therapeutics, Inc. (ACRV) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-18.98M |
|
-- |
|
-- |
|
$20.12M |
|
$-20.12M |
|
$1.13M |
|
$-18.98M |
|
$-18.98M |
|
$-18.98M |
|
$-18.98M |
|
$-18.98M |
|
$-18.98M |
|
$-20.12M |
|
$-19.62M |
|
38.51M |
|
38.51M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$120.44M |
|
$4.89M |
|
$9.27M |
|
$129.72M |
|
$15.66M |
|
-- |
|
$1.54M |
|
$17.20M |
|
$112.52M |
|
$112.52M |
|
$112.52M |
|
31.65M |
|
| Cash Flow Statement Financials | |
$-63.66M |
|
$66.10M |
|
$-0.75M |
|
$40.02M |
|
$41.70M |
|
$1.69M |
|
$14.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.69 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-65.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.87% |
|
-16.87% |
|
-14.64% |
|
-16.87% |
|
$3.56 |
|
$-1.70 |
|
$-1.65 |
|